Align Technology shares are tumbling in Wednesday's after-hours session after the company reported worse-than-expected results for the second quarter and issued soft guidance.
Dental technology company Align Technology (NASDAQ:ALGN) fell short of the market’s revenue expectations in Q2 CY2025, with sales falling 1.6% year on year to $1.01 billion. Next quarter’s revenue guidance of $975 million underwhelmed, coming in 6.4% below analysts’ estimates. Its non-GAAP profit of $2.49 per share was 3.3% below analysts’ consensus estimates.
After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable S&P500 performers among the top gainers and losers.
Dental technology company Align Technology (NASDAQ:ALGN)
will be announcing earnings results this Wednesday after market hours. Here’s what investors should know.
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment.
Even if a company is profitable, it doesn’t always mean it’s a great investment.
Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth.
Some of these companies also face challenges like stagnating revenue, declining market share, or limited scalability.
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets.
But the many opportunities in front of them attract significant competition, spanning from industry behemoths with seemingly infinite resources to small, nimble players with chips on their shoulders.
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns.
Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential.
However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the dental equipment & technology stocks, including Align Technology (NASDAQ:ALGN) and its peers.
A number of stocks fell in the afternoon session after the major indices pulled back (Nasdaq -1.3%, S&P 500 - 1.4%) as Treasury yields rose, reflecting market anxiety over a draft federal budget that could worsen the already wide US fiscal deficit. A poor auction for 20-year U.S. Treasury bonds further raised concerns, as weak demand implies investors are becoming more cautious about holding long-dated U.S. debt.
Dental technology company Align Technology (NASDAQ:ALGN) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 1.8% year on year to $979.3 million. The company expects next quarter’s revenue to be around $1.06 billion, close to analysts’ estimates. Its non-GAAP profit of $2.13 per share was 7.1% above analysts’ consensus estimates.
Curious about the top performers within the S&P500 index in the middle of the day on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Corporate buybacks surged in April, led by Apple, Alphabet, and Wells Fargo, signaling confidence and boosting stock prices. Tech and consumer companies also joining the buyback binge.
